ReP USP - Resultado da busca

Artigo de periodico
CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice (2020)
Wang, Chih-Hao; Lundh, Morten; Fu, Accalia; Kriszt, Rókus; Huang, Tian Lian; Lynes, Matthew D.; Leiria, Luiz Osório Silveira ; Shamsi, Farnaz; Darcy, Justin; Greenwood, Bennett P.; Narain, Niven R.; Tolstikov, Vladimir; Smith, Kyle L.; Emanuelli, Brice; Chang, Young-Tae; Hagen, Susan; Danial, Nika N.; Kiebish, Michael A.; Tseng, Yu-Hua
Fonte: Science Translational Medicine. Unidade: FMRP
Assuntos: TECIDO ADIPOSO, DIETA, OBESIDADE, TERMOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Chih-Hao et al. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine, v. 12, n. 558, 2020Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aaz8664. Acesso em: 28 jul. 2024.
APA
Wang, C. -H., Lundh, M., Fu, A., Kriszt, R., Huang, T. L., Lynes, M. D., et al. (2020). CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine, 12( 558). doi:10.1126/scitranslmed.aaz8664
NLM
Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LOS, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang Y-T, Hagen S, Danial NN, Kiebish MA, Tseng Y-H. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice [Internet]. Science Translational Medicine. 2020 ; 12( 558):[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.aaz8664
Vancouver
Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LOS, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang Y-T, Hagen S, Danial NN, Kiebish MA, Tseng Y-H. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice [Internet]. Science Translational Medicine. 2020 ; 12( 558):[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.aaz8664
Artigo de periodico
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression (2016)
Yong, Kol Jia; Bassères, Daniela Sanchez ; Welner, Robert S; Zhang, Wen Cai; Yang, Henry; Yan, Benedict; Jorda, Meritxell Alberich; Zhang, Junyan; Pontes, Lorena Lobo de Figueiredo; Battelli, Chiara; Hetherington, Christopher J; Ye, Min; Zhang, Hong; Maroni, Giorgia; O'Brien, Karen; Magli, Maria Cristina; Borczuk, Alain C; Varticovski, Lyuba; Kocher, Olivier; Zhang, Pu; Moon, Young-Choon; Sydorenko, Nadiya; Cao, Liangxian; Davis, Thomas W; Thakkar, Bhavin M; Soo, Ross A; Iwama, Atsushi; Lim, Bing; Halmos, Balazs; Neuberg, Donna; Tenen, Daniel G; Levantini, Elena
Fonte: Science Translational Medicine. Unidade: IQ
Assuntos: NEOPLASIAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YONG, Kol Jia et al. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression. Science Translational Medicine, v. 8, n. 350, p. 1-10 art. 350ra104, 2016Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aad6066. Acesso em: 28 jul. 2024.
APA
Yong, K. J., Bassères, D. S., Welner, R. S., Zhang, W. C., Yang, H., Yan, B., et al. (2016). Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression. Science Translational Medicine, 8( 350), 1-10 art. 350ra104. doi:10.1126/scitranslmed.aad6066
NLM
Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Jorda MA, Zhang J, Pontes LL de F, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon Y-C, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression [Internet]. Science Translational Medicine. 2016 ; 8( 350): 1-10 art. 350ra104.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.aad6066
Vancouver
Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Jorda MA, Zhang J, Pontes LL de F, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon Y-C, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression [Internet]. Science Translational Medicine. 2016 ; 8( 350): 1-10 art. 350ra104.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.aad6066
Artigo de periodico
Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection (2015)
Bailey, Adam L.; Lauck, Michael; Mohns, Mariel; Peterson, Eric J.; Beheler, Kerry; Brunner, Kevin G.; Crosno, Kristin; Mejia, Andres; Mutschler, James; Gehrke, Matthew; Greene, Justin; Ericsen, Adam J.; Weiler, Andrea; Lehrer-Brey, Gabrielle; Friedrich, Thomas C.; Sibley, Samuel D.; Kallas, Esper G.; Capuano III, Saverio; Rogers, Jeffrey; Goldberg, Tony L.; Simmons, Heather A.; O’Connor, David H.
Fonte: Science Translational Medicine. Unidade: FM
Assuntos: MACACOS, HEPATITE VIRAL HUMANA, INFECÇÕES OPORTUNISTAS, INFECÇÕES POR VÍRUS DE DNA, TESTES SOROLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAILEY, Adam L. et al. Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection. Science Translational Medicine, v. 7, p. 12 art. 305, 2015Tradução . . Disponível em: http://stm.sciencemag.org/content/7/305/305ra144.full-text.pdf+html. Acesso em: 28 jul. 2024.
APA
Bailey, A. L., Lauck, M., Mohns, M., Peterson, E. J., Beheler, K., Brunner, K. G., et al. (2015). Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection. Science Translational Medicine, 7, 12 art. 305. doi:10.1126/scitranslmed.aab3467
NLM
Bailey AL, Lauck M, Mohns M, Peterson EJ, Beheler K, Brunner KG, Crosno K, Mejia A, Mutschler J, Gehrke M, Greene J, Ericsen AJ, Weiler A, Lehrer-Brey G, Friedrich TC, Sibley SD, Kallas EG, Capuano III S, Rogers J, Goldberg TL, Simmons HA, O’Connor DH. Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection [Internet]. Science Translational Medicine. 2015 ; 7 12 art. 305.[citado 2024 jul. 28 ] Available from: http://stm.sciencemag.org/content/7/305/305ra144.full-text.pdf+html
Vancouver
Bailey AL, Lauck M, Mohns M, Peterson EJ, Beheler K, Brunner KG, Crosno K, Mejia A, Mutschler J, Gehrke M, Greene J, Ericsen AJ, Weiler A, Lehrer-Brey G, Friedrich TC, Sibley SD, Kallas EG, Capuano III S, Rogers J, Goldberg TL, Simmons HA, O’Connor DH. Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infection [Internet]. Science Translational Medicine. 2015 ; 7 12 art. 305.[citado 2024 jul. 28 ] Available from: http://stm.sciencemag.org/content/7/305/305ra144.full-text.pdf+html
Artigo de periodico
The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease (2015)
Sidman, Richard L; Li, Jianxue; Lawrence, Matthew; Hu, Wenzheng; Musso, Gary F; Giordano, Ricardo José ; Cardó-Vila, Marina; Pasqualini, Renata; Arap, Wadih
Fonte: Science Translational Medicine. Unidade: IQ
Assuntos: DOENÇAS RETINIANAS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIDMAN, Richard L et al. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, v. 7, p. 1-15 art. 309, 2015Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aac4882. Acesso em: 28 jul. 2024.
APA
Sidman, R. L., Li, J., Lawrence, M., Hu, W., Musso, G. F., Giordano, R. J., et al. (2015). The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, 7, 1-15 art. 309. doi:10.1126/scitranslmed.aac4882
NLM
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882
Vancouver
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882
Artigo de periodico
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies (2014)
Bettegowda, Chetan; Sausen, Mark; Leary, Rebecca J.; Kinde, Isaac; Wang, Yuxuan; Agrawal, Nishant; Bartlett, Bjarne R.; Wang, Hao; Luber, Brandon; Alani, Rhoda M.; Antonarakis, Emmanuel S.; Azad, Nilofer S.; Bardelli, Alberto; Brem, Henry; Cameron, John L.; Lee, Clarence C.; Fecher, Leslie A.; Gallia, Gary L.; Gibbs, Peter; Le, Dung; Giuntoli, Robert L.; Goggins, Michael; Hogarty, Michael D.; Holdhoff, Matthias; Hong, Seung-Mo; Jiao, Yuchen; Juhl, Hartmut H.; Kim, Jenny J.; Siravegna, Giulia; Laheru, Daniel A.; Lauricella, Calogero; Lim, Michael; Lipson, Evan J.; Nagahashi Marie, Suely Kazue; Netto, George J.; Oliner, Kelly S.; Olivi, Alessandro; Olsson, Louise; Riggins, Gregory J.; Sartore-Bianchi, Andrea; Schmidt, Kerstin; Shih, le-Ming; Oba-Shinjo, Sueli Mieko; Siena, Salvatore; Theodorescu, Dan; Tie, Jeanne; Harkins, Timothy T.; Veronese, Silvio; Wang, Tian-Li; Weingart, Jon D.; Wolfgang, Christopher L.; Wood, Laura D.; Xing, Dongmei; Hruban, Ralph H.; Wu, Jian; Allen, Peter J.; Schmidt, C. Max; Choti, Michael A.; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas; Diaz Jr., Luis A.
Fonte: Science Translational Medicine. Unidade: FM
Assuntos: DNA, BIOMARCADORES, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BETTEGOWDA, Chetan et al. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Science Translational Medicine, v. 6, n. 224, p. 11 , 2014Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.3007094. Acesso em: 28 jul. 2024.
APA
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., et al. (2014). Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Science Translational Medicine, 6( 224), 11 . doi:10.1126/scitranslmed.3007094
NLM
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong S-M, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Nagahashi Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih le-M, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang T-L, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz Jr. LA. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [Internet]. Science Translational Medicine. 2014 ; 6( 224): 11 .[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.3007094
Vancouver
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong S-M, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Nagahashi Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih le-M, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang T-L, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz Jr. LA. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [Internet]. Science Translational Medicine. 2014 ; 6( 224): 11 .[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.3007094
Artigo de periodico
Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers (2013)
Kinde, Isaac; Bettegowda, Chetan; Wang, Yuxuan; Wu, Jian; Agrawal, Nishant; Shih, Ie-Ming; Kurman, Robert; Dao, Fanny; Levine, Douglas A.; Giuntoli, Robert; Roden, Richard; Eshleman, James R.; Carvalho, Jesus Paula; Marie, Suely Kazue Nagahashi; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Diaz Jr., Luis A.
Fonte: Science Translational Medicine. Unidade: FM
Assuntos: DNA (AVALIAÇÃO), GENÓTIPOS, NEOPLASIAS OVARIANAS, ENDOMÉTRIO (PATOLOGIA), NEOPLASIAS UTERINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KINDE, Isaac et al. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers. Science Translational Medicine, v. 5, n. 167, p. 167ra4, 2013Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.3004952. Acesso em: 28 jul. 2024.
APA
Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I. -M., et al. (2013). Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers. Science Translational Medicine, 5( 167), 167ra4. doi:10.1126/scitranslmed.3004952
NLM
Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, Shih I-M, Kurman R, Dao F, Levine DA, Giuntoli R, Roden R, Eshleman JR, Carvalho JP, Marie SKN, Papadopoulos N, Kinzler KW, Vogelstein B, Diaz Jr. LA. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers [Internet]. Science Translational Medicine. 2013 ; 5( 167): 167ra4.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.3004952
Vancouver
Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, Shih I-M, Kurman R, Dao F, Levine DA, Giuntoli R, Roden R, Eshleman JR, Carvalho JP, Marie SKN, Papadopoulos N, Kinzler KW, Vogelstein B, Diaz Jr. LA. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers [Internet]. Science Translational Medicine. 2013 ; 5( 167): 167ra4.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.3004952
Artigo de periodico
Challenges in Using Stem Cells for Cardiac Repair (2010)
Mummery, Christine L.; Davis, Richard P.; Krieger, José Eduardo
Fonte: Science Translational Medicine. Unidade: FM
Assuntos: CÉLULAS-TRONCO (USO TERAPÊUTICO), PROCEDIMENTOS CIRÚRGICOS CARDÍACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUMMERY, Christine L. e DAVIS, Richard P. e KRIEGER, José Eduardo. Challenges in Using Stem Cells for Cardiac Repair. Science Translational Medicine, v. 2, n. 27, p. 27ps17, 2010Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.3000558. Acesso em: 28 jul. 2024.
APA
Mummery, C. L., Davis, R. P., & Krieger, J. E. (2010). Challenges in Using Stem Cells for Cardiac Repair. Science Translational Medicine, 2( 27), 27ps17. doi:10.1126/scitranslmed.3000558
NLM
Mummery CL, Davis RP, Krieger JE. Challenges in Using Stem Cells for Cardiac Repair [Internet]. Science Translational Medicine. 2010 ; 2( 27): 27ps17.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.3000558
Vancouver
Mummery CL, Davis RP, Krieger JE. Challenges in Using Stem Cells for Cardiac Repair [Internet]. Science Translational Medicine. 2010 ; 2( 27): 27ps17.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1126/scitranslmed.3000558

Unidades USP

ReP

Filtros

Autores

Autores USP

Ano de publicação

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos